APA (7th ed.) Citation

ML, F., QG, D., S, P., M, B., L, M., S, G., . . . R, P. (2019). Glioblastoma endothelium drives bevacizumab-induced infiltrative growth via modulation of PLXDC1. International journal of cancer, 144(6), 1331. https://doi.org/10.1002/ijc.31983

Chicago Style (17th ed.) Citation

ML, Falchetti, et al. "Glioblastoma Endothelium Drives Bevacizumab-induced Infiltrative Growth via Modulation of PLXDC1." International Journal of Cancer 144, no. 6 (2019): 1331. https://doi.org/10.1002/ijc.31983.

MLA (9th ed.) Citation

ML, Falchetti, et al. "Glioblastoma Endothelium Drives Bevacizumab-induced Infiltrative Growth via Modulation of PLXDC1." International Journal of Cancer, vol. 144, no. 6, 2019, p. 1331, https://doi.org/10.1002/ijc.31983.